Fig. 1 · Structure
Documents & Downloads
Zodasiran
ANGPTL3 inhibitor
Zodasiran is a small interfering RNA (siRNA) designed to inhibit angiopoietin-like protein 3 (ANGPTL3) in the liver. This inhibition plays a crucial role in lipid metabolism regulation, contributing to potential therapeutic applications in dyslipidemia and cardiovascular diseases. Zodasiran is a valuable tool for research studies focused on lipid regulation and metabolic disorders.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 2232918-66-8 |
| Applications | ANGPTL3 inhibitor |
| Formula | C491H646F13N162O309P43S7 |
| Molecular Weight | 15564.70 |
| Synonyms | ARO-ANG3 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.